RAS mutations predict radiologic and pathologic response in patients treated with chemotherapy prior to resection of colorectal liver metastases

類似資料

• RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases
  著者:: Vauthey, Jean-Nicolas, 等
  出版事項: (2013)
• Optimal Morphologic Response to Preoperative Chemotherapy: An Alternate Outcome End Point Before Resection of Hepatic Colorectal Metastases
  著者:: Shindoh, Junichi, 等
  出版事項: (2012)
• RAS mutation predicts positive resection margins and narrower resection margins in patients undergoing resection of colorectal liver metastases
  著者:: Brudvik, Kristoffer Watten, 等
  出版事項: (2016)
• Margin Status Remains an Important Determinant of Survival after Surgical Resection of Colorectal Liver Metastases in the Era of Modern Chemotherapy
  著者:: Andreou, Andreas, 等
  出版事項: (2013)
• Adjuvant Chemotherapy With FOLFOX for Primary Colorectal Cancer Is Associated With Increased Somatic Gene Mutations and Inferior Survival in Patients Undergoing Hepatectomy for Metachronous Liver Metastases
  著者:: Andreou, Andreas, 等
  出版事項: (2012)